Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 32,943 |
|
|||||
| News | - | ||||||
| Day High | 0.42 | Low High |
|||||
| Day Low | 0.38 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Trevena Inc | TRVN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.40 | 13:12:40 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4198 | 0.38 | 0.42 | 0.40 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 77 | 32,943 | US$ 0.4142105 | US$ 13,645 | - | 0.3001 - 3.28 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 13:17:45 | 100 | US$ 0.40 | USD |
Trevena Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.69M | 18.32M | - | 3.13M | -40.29M | -2.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Trevena News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/06/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/20/2024 | 15:06 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 2/14/2024 | 13:34 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/09/2024 | 15:05 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 2/01/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/23/2024 | 15:15 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/22/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 1/19/2024 | 15:30 | Edgar (US Regulatory) | Form S-3/A - Registration statement under Securities Act of.. |
| 1/10/2024 | 15:30 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 1/08/2024 | 06:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/28/2023 | 13:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/15/2023 | 17:57 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3586 | 0.42 | 0.3487 | 0.3940642 | 76,262 | 0.0414 | 11.54% |
| 1 Month | 0.40 | 0.43 | 0.3001 | 0.3894203 | 355,550 | 0.00 | 0.00% |
| 3 Months | 0.6068 | 0.70 | 0.3001 | 0.4533031 | 214,128 | -0.2068 | -34.08% |
| 6 Months | 0.5111 | 0.7693 | 0.3001 | 0.5156155 | 152,523 | -0.1111 | -21.74% |
| 1 Year | 0.67 | 3.28 | 0.3001 | 1.95 | 1,009,782 | -0.27 | -40.30% |
| 3 Years | 42.50 | 55.00 | 0.3001 | 16.38 | 1,120,452 | -42.10 | -99.06% |
| 5 Years | 37.50 | 112.50 | 0.3001 | 39.98 | 1,931,526 | -37.10 | -98.93% |
Trevena Description
| Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain. |
